HHMI
ALB icon

Howard Hughes Medical Institute’s Albemarle ALB Stock Holding History

Howard Hughes Medical Institute’s Portfolio ALB Stock Details ALB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-25
Closed -$3.54K – 50
2025
Q4 		$3.54K Hold
25
– – ﹤0.01% 412
2025
Q3 		$2.03K Hold
25
– – ﹤0.01% 471
2025
Q2 		$1.57K Buy
+25
New +$1.48K ﹤0.01% 488

Other funds holding ALB

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Howard Hughes Medical Institute's ALB Position: Q1 2026 in Review

Howard Hughes Medical Institute sold out of Albemarle (ALB) in Q1 2026, closing a stake of 25 shares — an estimated $3.54K sold.

Howard Hughes Medical Institute first reported a position in ALB in Q2 2025 and held it in 3 quarters. The position peaked at $3.54K in Q4 2025. 983 funds tracked by Wall St. Rank hold ALB as of Q1 2026.

  • Howard Hughes Medical Institute reported no remaining Albemarle position as of Q1 2026 after selling out during the quarter.
  • Howard Hughes Medical Institute sold 25 Albemarle shares in Q1 2026, an estimated $3.54K.
  • Howard Hughes Medical Institute first reported a position in Albemarle in Q2 2025 and held it in 3 quarters.
  • Howard Hughes Medical Institute's Albemarle position peaked at $3.54K in Q4 2025.
  • 983 funds tracked by Wall St. Rank held Albemarle as of Q1 2026.

Based on Howard Hughes Medical Institute's 13F filing for Q1 2026, filed 15 May 2026.